mGPfusion: Predicting protein stability changes with Gaussian process
  kernel learning and data fusion by Jokinen, Emmi et al.
mGPfusion: Predicting protein stability changes with
Gaussian process kernel learning and data fusion
Emmi Jokinen1, Markus Heinonen1,2 and Harri La¨hdesma¨ki1
1Department of Computer Science, Aalto University, 02150 Espoo, Finland
2Helsinki Institute for Information Technology, Finland
Abstract
Motivation: Proteins are commonly used by biochemical industry for numerous processes. Refining these proteins’ properties via
mutations causes stability effects as well. Accurate computational method to predict how mutations affect protein stability are necessary
to facilitate efficient protein design. However, accuracy of predictive models is ultimately constrained by the limited availability of
experimental data.
Results: We have developed mGPfusion, a novel Gaussian process (GP) method for predicting protein’s stability changes upon single
and multiple mutations. This method complements the limited experimental data with large amounts of molecular simulation data.
We introduce a Bayesian data fusion model that re-calibrates the experimental and in silico data sources and then learns a predictive
GP model from the combined data. Our protein-specific model requires experimental data only regarding the protein of interest and
performs well even with few experimental measurements. The mGPfusion models proteins by contact maps and infers the stability
effects caused by mutations with a mixture of graph kernels. Our results show that mGPfusion outperforms state-of-the-art methods in
predicting protein stability on a dataset of 15 different proteins and that incorporating molecular simulation data improves the model
learning and prediction accuracy.
Availability: Software implementation and datasets are available at github.com/emmijokinen/mgpfusion
Contact: emmi.jokinen@aalto.fi
1 Introduction
Proteins are used in various applications by pharmaceutical, food, fuel,
and many other industries and their usage is growing steadily (Kirk
et al., 2002; Sanchez and Demain, 2010). Proteins have important ad-
vantages over chemical catalysts, as they are derived from renewable
resources, are biodegradable and are often highly selective (Cherry and
Fidantsef, 2003). Protein engineering is used to further improve the
properties of proteins, for example to enhance their catalytic activity,
modify their substrate specificity or to improve their thermostability
(Rapley and Walker, 2000). Increasing the stability is an important as-
pect of protein engineering, as the proteins used in industry should be
stable in the industrial process conditions, which often involve higher
than ambient temperature and non-aqueous solvents (Bommarius et al.,
2011). The properties of a protein are modified by introducing alter-
ations to its amino acid sequence. Mutations in general tend to be
destabilising, and if too many destabilising mutations are implemented,
the protein may not remain functional without compensatory stabilis-
ing mutations (Tokuriki and Tawfik, 2009).
The stability of a protein can be defined as the difference in Gibbs
energy ∆G between the folded and unfolded (or native and denatu-
rated) state of the protein. More precisely, the Gibbs energy difference
determines the thermodynamic stability ∆Gt of the protein, as it does
not take into account the kinetic stability ∆Gk which determines the
energy needed for the transition between the folded and unfolded states
(Anslyn and Dougherty, 2006) (see Supplementary Figure S1). Here we
will consider only the thermodynamic stability and from now on it will
be referred to merely as stability ∆G.
The effect of mutations can be defined by the change they cause
to the Gibbs energy ∆G, denoted as ∆∆G (Pace and Scholtz, 1997).
To comprehend the significance of stability changes upon mutations,
we can consider globular proteins, the most common type of enzymes,
whose polypeptide chain is folded up in a compact ball-like shape with
an irregular surface (Alberts et al., 2007). These proteins are only
marginally stable and the difference in Gibbs energy between the folded
and unfolded state is only about 5–15 kcal/mol, which is not much more
than the energy of a single hydrogen bond that is about 2–5 kcal/mol
(Branden and Tooze, 1999). Therefore, even one mutation that breaks
a hydrogen bond can prevent a protein from folding properly.
The protein stability can be measured with many techniques, in-
cluding thermal, urea and guanidinium chloride (GdmCl) denaturation
curves that are determined as the fraction of unfolded proteins at dif-
ferent temperatures or at different concentrations of urea or GdmCl
(Pace and Shaw, 2000). Some of the experimentally measured sta-
bility changes upon mutations have been gathered in thermodynamic
databases such as Protherm (Kumar et al., 2006).
A variety of computational methods have been introduced to predict
the stability changes upon mutations more effortlessly than through ex-
perimental measurements. These methods utilise physics or knowledge-
based potentials (Leaver-Fay et al., 2011), their combinations, or differ-
ent machine learning methods. The machine learning methods utilise
support vector machines (SVM) (Capriotti et al., 2005b, 2008; Chen
et al., 2013; Cheng et al., 2006; Folkman et al., 2014; Liu and Kang,
2012; Pires et al., 2014a), random forests (Tian et al., 2010; Wainreb
et al., 2011), neural networks (Dehouck et al., 2009; Giollo et al., 2014),
and Gaussian processes (Pires et al., 2014b). However, it has been as-
sessed that although on average many of these methods provide good
results, they tend to fail on details (Potapov et al., 2009). In addition,
many of these methods are able to predict the stability effects only for
single-point mutations.
We introduce mGPfusion (mutation Gaussian Processes with data
fusion), a method for predicting stability effects of both point and mul-
tiple mutations. mGPfusion is a protein-specific model – in contrast to
earlier stability predictors that aim to estimate arbitrary protein struc-
ture or sequence stabilities – and achieves markedly higher accuracy
while utilising data only from a single protein at a time. In contrast
to earlier works that only use experimental data to train their models,
we also combine exhaustive Rosetta (Leaver-Fay et al., 2011) simulated
point mutation in silico stabilities to our training data.
A key part of mGPfusion is the automatic scaling of simulated data
to better match the experimental data distribution based on those vari-
ants that have both experimental and simulated stability values. Fur-
thermore, we estimate a variance resulting from the scaling, which
places a higher uncertainty on very destabilising simulations. Our
Gaussian process model then utilises the joint dataset with their es-
timated heteroscedastic variances and uses a mixture of graph kernels
to assess the stability effects caused by changes in amino acid sequence
according to 21 substitution models. Our experiments on a novel 15
protein dataset show a state-of-the-art stability prediction performance,
which is also sustained when there is access only to a very few experi-
mental stability measurements.
1
ar
X
iv
:1
80
2.
02
85
2v
2 
 [s
tat
.M
L]
  2
3 M
ar 
20
18
Figure 1: Pipeline illustration for mGPfusion. a) M = 21 substitution matrices utilise different information sources and give scores to pairwise amino
acid substitutions. b) The wild-type structures from Protein Data Bank are modelled as contact graphs. c) The graph kernel measures similarity of two
sequences by a substitution model S over all positions p and their neighbourhoods nbs(p) in the contact graph. d) Each substitution matrix is used to
create a separate covariance matrix. e) Multiple kernel learning (MKL) is used for finding the optimal combination of the base kernels. The kernel matrix
measures variant similarities. f) Experimentally measured ∆∆G values yE are gathered from Protherm and Rosetta’s ddg monomer application is used to
simulate the stability effects yS for all single point mutations. g) Bayesian scaling for the simulated values yS at the x-axis. Possible scalings are coloured
with green and the chosen scaling from yS into scaled values y˜S is marked by black dots. The scaling is fitted to a subset of experimentally measured
stabilities yE (circles). h) The stability predictive GP model is trained using experimental and simulated data through the kernel matrix.
2 Methods
Following Pires et al. (2014b) we choose a Bayesian model family of
Gaussian processes for prediction of mutation effects on protein sta-
bility due to its inherent ability to handle uncertainty in a principle
way. Bayesian modelling is a natural approach for combining the ex-
perimental and simulated data distribution, while it is also suitable for
learning the underlying mixture of substitution models that governs the
mutational process.
The pipeline for mGPfusion is presented in Figure 1. The first
part of mGPfusion consists of collection of in silico and experimental
datasets discussed in Section 2.1, the scaling of the in silico dataset in
Section 2.2 and the fusion of these two datasets in Section 2.3. The sec-
ond part consists of the Gaussian process model described in Section 2.4
with detailed description of the graph kernels in Sections 2.5-2.6 and
model inference in Section 2.7. Finally, the evaluation criteria used are
described in Section 2.8.
2.1 Experimental and in silico data
Protherm is a database of numerical thermodynamic parameters for
proteins and their mutants (Kumar et al., 2006). From Protherm we
gathered all proteins with at least 50 unique mutations whose ∆∆G
has been measured by thermal denaturation, and where a PDB code
for a 3D structure of the protein was reported. We required the pro-
teins to have at least 50 unique mutations, so that we would have a
representative test set and get sufficiently reliable estimates of predic-
tion accuracy on individual proteins and examine how the amount of
experimental training data affects the accuracy of the model. The 3D
structures are necessary for obtaining the connections between residues.
We collected the 3D structures with the reported PDB codes from the
Protein Databank, www.rcsb.org (Berman et al., 2000). The 15 pro-
teins that fulfilled these requirements are listed in Table 1. We aver-
aged the stability values for proteins with multiple measurements and
ignored mutations to residues not present in their 3D structures. These
data sets are available at github.com/emmijokinen/mgpfusion.
Protein (organism) PDB
mutations
all point point (sim)
T4 Lysozyme (Enterobacteria phage T4) 2LZM 349 264 3116
Barnase (Bacillus amyloliquefaciens) 1BNI 182 163 2052
Gene V protein (Escherichia virus m13) 1VQB 124 92 1634
Glycosyltransferase A (Homo sapiens) 1LZI 116 114 2470
Chymotrypsin inhibitor 2 (Hordeum vulgare) 2CI2 98 77 1235
Protein G (Streptococcus sp. gx7805) 1PGA 89 34 1064
Ribonuclease H (Escheria coli) 2RN2 83 65 2945
Cold shock protein B (Bacillus subtilis) 1CSP 80 50 1273
Apomyoglobin (Physeter catodon) 1BVC 80 56 2907
Hen egg white lysozyme (Gallus gallus) 4LYZ 63 50 2451
Ribonuclease A (Bos taurus) 1RTB 57 50 2356
Peptidyl-prolyl cis-trans isomerase (Homo sapiens) 1PIN 56 56 2907
Ribonuclease T1 isozyme (Aspergillus oryzae) 1RN1 53 48 1957
Ribonuclease (Streptomyces auerofaciens) 1RGG 54 45 1824
Bovine pancreatic trypsin inhibitor (Bos taurus) 1BPI 53 47 1102
total 1537 1211 31293
Table 1: The 15 protein data from ProTherm database with counts of point
mutations, all mutations, and of simulated point mutation stability changes.
We also generate simulated data of the stability effects of all possible
single mutations of the proteins. Our method can utilise any simulated
stability values. We used the “ddG monomer” application of Rosetta
3.6 (Leaver-Fay et al., 2011) using the high-resolution backrub-based
protocol 16 recommended in Kellogg et al. (2011). The predictions yS
made with Rosetta are given in Rosetta Energy Units (REU). Kellogg
et al. (2011) suggest transformation 0.57yS for converting the predic-
tions into physical units. The simulated data scaled this way is not
as accurate as the experimental data, the correlation and root mean
2
square error (rmse) with respect to the experimental data are shown
for all proteins in Table 2 and for individual proteins in Supplementary
Table S2, on rows labelled Rosetta. For this reason, we use instead a
Bayesian scaling described in the next section and different noise models
for the experimental and simulated data, described in Section 2.3.
For each of the 15 proteins, let xi = (xi1, . . . , xiM ) denote its
M -length variant i with positions p labelled with residues xip ∈
{A,R,N, . . . , V }. We denote the wild-type protein as x0. We collect
15 separate sets of simulated and experimental data. We denote the
NE experimental variants of each protein as XE = (x
E
1 , . . . ,x
E
NE
)T with
the corresponding experimental stability values yE = (y
E
1 , . . . , y
E
NE
)T ∈
RNE . Similarly, we denote the NS simulated observations as XS =
(xS1 , . . . ,x
S
NS
)T and yS = (y
S
1 , . . . , y
S
NS
)T ∈ RNS .
2.2 Bayesian scaling of in silico data
The described transformation from REU to physical units may not
be optimal for all proteins. We therefore applied instead a linear-
exponential scaling function to obtain scaled Rosetta simulated sta-
bilities y˜S ,
y˜S = g(yS | θj) = ajecjyS + bjyS + dj . (1)
This scaling transforms the Rosetta simulations yS for each protein
j = 1, . . . , 15 to correspond better to the experimental data. The pa-
rameters θj = (aj , bj , cj , dj) define the weight aj and steepness cj of the
exponential term, while the linear term has slope bj and intercept dj .
To avoid overfitting, we perform Bayesian linear regression and start
by defining parameter prior p(θj) = p(aj)p(bj)p(cj)p(dj) that reflects
our beliefs about realistic scalings having only moderate steepness:
p(aj) = Gamma(aj |αa, βa)
p(bj) = Beta(1/2 · bj |αb, βb)
p(cj) = Beta(10/3 · cj |αc, βc)
p(dj) = N (dj |µd, σ2d).
(2)
The empirically selected hyperparameter values are listed in Supple-
mentary Table S1 and the priors are illustrated in Figure S2.
We compute the posterior for θj using the subset of simulated data
that have corresponding experimentally measured data:
p(θj |yE ,yS) ∝
∏
i:xi∈XE∩XS
N (yEi | g(ySi |θj), σ2n) p(θj).
The product iterates over all NE∩S simulated ∆∆G’s that have a
matching experimentally observed value. The σ2n is the scaling error
variance, which was set to σ2n = 0.5. The parameters θ for each protein
were sampled using a random walk Metropolis-Hastings MCMC algo-
rithm (the mhsample function in Matlab) for NMC = 10000 samples
with a burn-in set to 500. The proposal distribution was selected to be
a symmetric uniform distribution such that [as+1, bs+1, cs+1, ds+1] ∼
U(as ± 0.4, bs ± 0.04, cs ± 0.04, ds ± 0.4). Given the sample of scaling
parameters (θ
(s)
j )
NMC
s=1 , we define the scaled simulated data as the aver-
age scaling over the MCMC sample, and record also the sample scaling
variance
y˜Si =
1
NMC
NMC∑
s=1
g(ySi |θ(s)j ) (3)
σ2T (i) =
1
NMC
NMC∑
s=1
(
g(ySi |θ(s)j )− y˜Si
)2
. (4)
See Figure 1 g) for an illustration of the scaling. We collect the scaled
simulated value and its variance from each simulated point into vectors
y˜S = (y˜
S
1 , . . . , y˜
S
NS
) and σ2T = (σ
2
T (1), . . . , σ
2
T (NS)) ∈ RNS .
2.3 Data fusion and noise models
For each protein j, we organise its experimental data (XE ,yE) and
transformed simulated data (XS , y˜S) along with the wild-type infor-
mation (x0, y0) into a single joint dataset of variants X = (x0, XE , XS)
and stabilities y = (y0,yE , y˜S) of size RN where N = 1 +NE +NS is
the total number of simulated and experimental data points, including
the wild-type. We assume heteroscedastic additive noise models for the
three information sources
y0 = f (x0) + ε0, ε0 ∼ N
(
0, σ20
)
yEi = f
(
xEi
)
+ εEi , ε
E
i ∼ N
(
0, σ2E
)
(5)
y˜Si = f
(
xSi
)
+ εSi , ε
S
i ∼ N
(
0, (σE + σS + tσT (i))
2
)
,
where the observed values are noisy versions of the underlying ‘true’
stability function f(x) corrupted by zero-mean noise with data source
specific variances. We learn a Gaussian process based stability function
f(x) in the next Section.
The Equations (5) encode that the experimental data are corrupted
by a global experimental noise variance σ2E . The simulated stabilities
are additionally corrupted by a global Rosetta simulator error variance
σ2S , and by the value-dependent transformation variance tσ
2
T (i) scaled
by parameter t. The model then encapsulates that we trust the Rosetta
data less than the experimental data. By definition, the ∆∆G of the
wild-type is zero (y0 = 0) with very small assumed error, σ0 = 10
−6.
Note that σ2T are fixed by equation (4), while we infer the optimal
values for the remaining three free parameters (σE , σR, t) (See Section
2.4). The parameters σ2E and σ
2
S are assigned priors
σE ∼ Gamma(σE |αE , βE)
σS ∼ Gamma(σR|αS , βS).
(6)
The values of these hyperparameters are shown in Supplementary Ta-
ble S1.
2.4 Gaussian processes
We use a Gaussian process (GP) function f to predict the stability
f(x) ∈ R of a protein variant x. Gaussian processes are a family of
non-parametric, non-linear Bayesian models (Rasmussen and Williams,
2006). A zero-mean GP prior
f(x) ∼ GP (0, k(x,x′)) ,
defines a distribution over functions f(x) whose mean and covariance
are
E[f(x)] = 0
cov[f(x), f(x′)] = k(x,x′).
For any collection of protein variants X = x1, . . . ,xN , the function val-
ues follow a multivariate normal distribution f ∼ N (0,KXX), where
f = (f(x1), . . . , f(xN ))
T ∈ RN , and where KXX ∈ RN×N with
[KXX ]ij = k(xi,xj). The key property of Gaussian processes is that
they encode functions that predict similar stability values f(x), f(x′)
for protein variants x,x′ that are similar, as encoded by the kernel
k(x,x′). The key part of GP modelling is then to infer a kernel that
measures the mutation’s effects to the stability.
Let a dataset of noisy stability values from two sources be y ∈ RN ,
the corresponding protein structures X = (xi)
N
i=1, and a new protein
variant x∗ whose stability we wish to predict. A Gaussian process de-
fines a joint distribution over the observed values y of variants X, and
the unknown function value f(x∗) of the unseen variant x∗,[
y
f(x∗)
]
∼ N
(
0,
[
KXX + diag(σ
2) kX∗
k∗X k(x∗,x∗)
])
,
where kX∗ = kT∗X ∈ RN is a kernel vector with elements k(xi,x∗) for
all i = 1, . . . , N , and where σ2 = (σ20 , σ
2
E1
T , (σE1
T +σS1
T + tσT
T )2)T
collects final variances of the data points from equations (5). Here
the exponents are elementwise. The conditional distribution gives the
posterior distribution of the stability prediction as
f(x∗)|(X,y) ∼ N
(
µ(x∗), σ2(x∗)
)
,
where the prediction mean and variance are
µ(x∗) = k∗X
(
KXX + diag(σ
2)
)−1
y,
σ2(x∗) = k(x∗,x∗)− k∗X
(
KXX + diag(σ
2)
)−1
kX∗.
3
Hence, in GP regression the stability predictions µ(x∗) ± σ(x∗) will
come with uncertainty estimates.
2.5 Graph kernel
Next, we consider how to compute the similarity function k(x,x′) be-
tween two variants of the same protein structure. We will encode the
3D structural information of the two protein variants as a contact map
and measure their similarity by the formalism of graph kernels (Vish-
wanathan et al., 2010).
We consider two residues to be in contact if their closest atoms are
within 5 A˚ of each other in the PDB structure, which is illustrated in
Figure 1 b). All variants of the same protein have the same length, with
only different residues at mutating positions. Furthermore, we assume
that all variants share the wild-type protein contact map.
To compare protein variants, we construct a weighted decomposition
kernel (WDK) (Menchetti et al., 2005) between two protein variants
x = (x1, . . . , xM ) and x
′ = (x′1, . . . , x
′
M ) of length M ,
k(x,x′) =
M∑
p=1
S(xp, x′p) ∑
l∈nbs(p)
S(xl, x
′
l)
, (7)
where nbs(p) defines the set of neighbouring positions to position p,
and S is a substitution matrix. The kernel iterates over all positions
p and compares for each of them their residues through a substitution
matrix S(xp, x
′
p). Furthermore, the similarity of the residues at each
position is multiplied by the average similarity of the residues at its
neighbouring positions S(xl, x
′
l). Hence, the kernel defines the simi-
larity of two protein variants as the average position and neighbour-
hood similarity over all positions. The kernel matrix is normalised
so that for two data points, the normalised kernel is kˆ(xp, x
′
p) =
k(xp, x
′
p)/
√
k(xp, xp)k(x′p, x′p), as defined by Shawe-Taylor and Cris-
tianini (2004). The kernel is illustrated in Figure 1 c).
The above WDK kernel allows us to compare the effects of multiple
simultaneous mutations. However, as the wild type protein structure
is used for all of the protein variants, changes that the mutations may
cause to the protein structure are not taken into consideration. This
may cause problems if mutations that alter the protein structure sig-
nificantly are introduced – especially if many of them are introduced
simultaneously. On the other hand, substitution matrices that have
their basis in sequence comparisons, should take these effects into ac-
count to some extend as these kinds of mutations are usually highly
destabilising and do not occur often in nature. In the next section, we
will discuss how we utilise different substitution matrices with multiple
kernel learning.
2.6 Substitution matrices and multiple kernel
learning
The BLOSUM substitution models have been a common choice for
protein models (Giguere et al., 2013), while mixtures of substitution
models were proposed by Cichonska et al. (2017). BLOSUM matrices
score amino acid substitutions by their appearances throughout evolu-
tion, as they compare the frequencies of different mutations in similar
blocks of sequences (Henikoff and Henikoff, 1992). However, there are
also different ways to score amino acids substitutions, such as chemical
similarity and neighbourhood selectivity (Tomii and Kanehisa, 1996).
When the stability effects of mutations are evaluated, the frequency of
an amino acid substitution in nature may not be the most important
factor.
To take into account different measures of similarity between amino
acids, we employed a set of 21 amino acid substitution matrices gath-
ered from AAindex21 (Kawashima et al., 2008). AAindex2 currently
contains 94 substitution matrices. From these we selected those that
had no gaps concerning substitutions between the 20 naturally occur-
ring amino acids and scaled them between zero and one as
S =
S0 −min(S0) + 1
max(S0)−min(S0) + 1 . (8)
Out of these matrices, we only chose those 23 matrices that were pos-
itive semidefinite. Furthermore, there were two pairs of matrices that
were extremely similar, and we only selected one matrix from each pair,
ending up with 21 substitution matrices. These substitution matrices
are used together with Equation 7 for computing 21 base kernel matri-
ces. Finally, MKL is used to find an optimal combination of the base
kernels of form
Kφ =
21∑
m=1
wmK
(γm)
m , (9)
where wm is a kernel specific weight, γm is an (elementwise) exponent.
The elementwise exponent retains the SDP property of Kφ (Shawe-
Taylor and Cristianini, 2004). We observe empirically that the optimal
kernel weights wm tend to be sparse (See Figure 2).
The selected substitution matrices are listed in Figure 2. These ma-
trices have different basis and through multiple kernel learning (MKL)
our model learns which of these are important for inferring the stability
effects that mutations cause on different proteins. The figure illustrates
this by showing the average weights of the base kernel matrices obtained
via the multiple kernel learning.
2.7 Parameter inference
The complete model has five parameters φ = (σE , σS , t,w,γ) to in-
fer, of which the variance parameters (σE , σS , t) parameterise the joint
data variance σ2φ, while the MKL parameters w = (w1, . . . , w21) and
γ = (γ1, . . . , γ21) parameterise the kernel matrix Kφ. In a Gaussian
process model these can be jointly optimised by the marginal (log)
likelihood with priors
log p(y|φ)p(σE)p(σR) = log
∫
p(y|f , φ)p(f |φ)p(σE)p(σR)df
∝ −1
2
yT (Kφ + diag(σ
2
φ))
−1y − 1
2
log |Kφ + diag(σ2φ)|
+ log Gamma(σE |αE , βE) + log Gamma(σS |αS , βS),
(10)
which automatically balances model fit (the square term) and the
model complexity (the determinant) to avoid overfitting (Rasmussen
and Williams, 2006). The parameters can be optimised by maximis-
ing the marginal log likelihood (10) using gradient ascent, since the
marginal likelihood can be differentiated analytically (see Supplemen-
tary Equations S1 and S2). We utilised a limited-memory projected
quasi-Newton algorithm (minConf TMP2), described by (Schmidt et al.,
2009).
2.8 Evaluation criteria
We chose to evaluate the accuracy of our predictions using the same
metrics that have been used by many others – correlation ρ between the
predicted and experimentally measured ∆∆G values (Capriotti et al.,
2005a; Dehouck et al., 2009; Kellogg et al., 2011; Pires et al., 2014b;
Potapov et al., 2009) and the root mean square error (rmse) (Dehouck
et al., 2009; Pires et al., 2014a,b), which are determined in the Supple-
mentary Equations S3 and S4. We use marginal likelihood maximisa-
tion to infer model parameters and perform cross-validation to evaluate
the model performance on test data. Below we only report evaluation
metrics obtained from the test sets not used at any stage of the model
learning or data transformation sampling.
3 Results
In this section we evaluate the performance of mGPfusion on predict-
ing stability effects of mutations, and compare it to the state-of-the-
art prediction methods mCSM, PoPMuSiC and Rosetta. Rosetta is a
1http://www.genome.jp/aaindex/
2http://www.cs.ubc.ca/~schmidtm/Software/minConf.html
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Figure 2: Average weights for kernels utilising the described substitution matrices from AAindex2, when GP models were trained with mutation level
cross-validation. Basis for the substitution matrices are obtained from (Tomii and Kanehisa, 1996). ∗ were added to AAindex2 in a later release, and their
basis were not determined by Tomii and Kanehisa (1996).
molecular modelling software whose ddg monomer module can directly
simulate the stability changes ∆∆G of a protein upon mutations. PoP-
MuSic and mCSM are machine learning models that predict stability
based on protein variant features. We run Rosetta locally, and use
mCSM and PoPMuSiC models through their web servers3. This may
give these methods an advantage over mGPfusion since parts of our
testing data were likely used within their training data.
We compare four different variants of our method: mGPfusion that
uses both simulated data and MKL, “mGPfusion, only B62” that uses
simulated data but incorporates only one kernel matrix (BLOSUM62
substitution matrix), mGP model that uses MKL but does not use simu-
lated data, and “mGP, only B62” that uses only the base GP model but
does not incorporate simulated data and uses only the BLOSUM62 sub-
stitution matrix. In addition, we experiment on transforming Rosetta
predictions with the Bayesian scaling. We perform the experiments
for the 15 proteins separately using either position or mutation level
(leave-one-out) cross-validation regarding the methods mGP, mGPfu-
sion and the Bayesian scaling of Rosetta. Pires et al. (2014b) used
protein and position level cross-validation to evaluate their model. In
protein level cross-validation all mutations in a protein are either in
the test or training set exclusively. When we train our model using
protein level cross-validation, we use no experimental data and rely
only on the simulated data. Position level cross-validation is defined
so that all mutations in a position are either in the test or training set
exclusively. However, datasets in Pires et al. (2014b) contained only
point mutations and therefore we had to extend the definition to also
include multiple mutations. In position level cross-validation we train
one model for each position using only the part of data that has a
wild-type residue in that position. Therefore, in position level cross-
validation we construct a test set that contains all protein variants that
have a mutation at position p and use as training set all the protein
variants that have a wild-type residue at that position. Dehouck et al.
(2009) evaluated their models by randomly selecting training and test
sets so that each mutation was exclusively in one of the sets, but both
sets could contain mutations from the same position of the same pro-
tein. We call this mutation level cross-validation. When we use all
available experimental data with mutation level cross-validation, this
corresponds to leave-one-out cross-validation.
3.1 Predicting point mutations
Table 2 summarises the average prediction performance over all 15 pro-
teins for all compared methods, types of mutations and cross-validation
types. We first compare the performances on single point mutations,
where mGPfusion and mGP achieve the highest performance with
ρ = 0.81 and rmse = 1.07 kcal/mol, and ρ = 0.81 and rmse = 1.04
kcal/mol, respectively with mutation level cross-validation. With only
one kernel utilising the BLOSUM62 matrix instead of MKL, the per-
formance decreases slightly, but the competing methods are still out-
performed, as mCSM achieves ρ = 0.64 and rmse = 1.37 kcal/mol,
PoPMuSic ρ = 0.61 and Rosetta ρ = 0.55. Applying Bayesian scaling
on Rosetta simulator improves the performance of standard Rosetta
from ρ = 0.55 to ρ = 0.65 and decreases the rmse from 1.63 kcal/mol
to 1.35 kcal/mol, which is interestingly even slightly better than the
performances of mCSCM and PoPMuSiC.
With position level cross-validation mGPfusion achieves the high-
est performance of ρ = 0.70 and rmse = 1.26 kcal/mol, likely due
to having still access to simulated variants from that position, since
they are always available to the learner. Without simulation data,
the baseline machine learning model mGP performance decreases to
ρ = 0.51 and rmse = 1.54 kcal/mol, thus demonstrating the impor-
tance of the data fusion. Cross-validation could not be performed for
the off-the-shelf methods mCSM and PoPMuSiC. Even still, mGPfusion
(trained with one or multiple kernels) outperforms competing state-of-
the-art methods and achieves markedly higher prediction performance
as quantified by both mutation and position level cross-validations.
Also mGP outperforms these methods when quantified by mutation
level cross-validation. With protein level cross-validation mGPfusion
achieves slightly better results than Rosetta.
3biosig.unimelb.edu.au/mcsm and
omictools.com/popmusic-tool
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Correlation ρ rmse
Point mutations Multiple mutations All mutations Point mutations Multiple mutations All mutations
cross-validation level cross-validation level cross-validation level cross-validation level cross-validation level cross-validation level
Method mut. pos. prot. mut. pos. prot. mut. pos. prot. mut. pos. prot. mut. pos. prot. mut. pos. prot.
mGPfusion 0.81 0.70 0.56 0.88 0.61 0.49 0.83 0.64 0.52 1.07 1.26 1.61 1.33 2.45 2.53 1.13 1.87 1.84
mGPfusion, only B62 0.79 0.69 0.56 0.86 0.64 0.50 0.82 0.66 0.52 1.11 1.30 1.62 1.43 2.40 2.50 1.18 1.85 1.84
mGP 0.81 0.51 - 0.86 0.52 - 0.83 0.50 - 1.04 1.54 - 1.44 2.65 - 1.14 2.09 -
mGP, only B62 0.76 0.34 - 0.86 0.55 - 0.80 0.49 - 1.26 1.95 - 1.45 2.56 - 1.30 2.23 -
Rosetta scaled 0.65 0.63 - 0.51 0.39 - 0.60 0.48 - 1.35 1.38 - 2.49 2.99 - 1.66 2.22 -
Predictions from off-the-shelf implementations with no cross-validation
Rosetta 0.55 0.40 0.49 1.63 2.74 1.92
mCSM 0.61 - - 1.40 - -
PoPMuSiC 0.64 - - 1.37 - -
Table 2: Comparison of different methods on the 15 protein dataset with respect to ρ and rmse. Mutation, position, and protein are referred to as mut.,
pos., and prot., respectively. Predictions from off-the-shelf implementations of Rosetta, mCSM and PoPMuSiC are used directly without cross-validation.
3.2 Predicting multiple mutations
Next, we tested stability prediction accuracies for variants containing
either single or multiple mutations. Figure 3 shows a scatter plot of
mGPfusion predictions for all 1537 single and multiple mutation vari-
ants (covering all 15 proteins) against the experimental ∆∆G values
using the mutation level (leave-one-out) cross-validation. The points
are coloured by the number of simultaneous mutations in the variants,
with 326 variants having at least 2 mutations (See Table 1). Fig-
ure 3 illustrates the mGPfusion’s overall high accuracy of ρ = 0.83
and rmse = 1.13 kcal/mol on both single and multiple mutations (See
Table 2). Scatter plots for the individual proteins can be found in Sup-
plementary Figure S3. Dehouck et al. (2009) suggested that considering
the predictive power after removal of most badly predicted stability ef-
fects of mutations may give more relevant evaluation, as some of the
experimental measurements may have been made in non-physiological
conditions or affected by significant error, associated with a poorly re-
solved structure, or indexed incorrectly in the database. They thus
reported correlation and rmse of the predictions after excluding 10 %
of the predictions with most negative impacts on the correlation co-
efficient. Pires et al. (2014b) also reported their accuracy after 10 %
outlier removal. If we remove the 10% worst predicted stability effects
from the combined predictions, we achieve correlation ρ of 0.92 and
rmse of 0.67 kcal/mol. We report these results for all the methods
in Supplementary Table S3 and also present the error distribution in
Supplementary Figure S5.
Figure 3: Scatter plot for the mutation level (leave-one-out) predictions made
for all 15 proteins (See Table 1). The colour indicates the number of simul-
taneous mutations.
The high accuracy is retained for variants with multiple mutations
as well (ρ = 0.88 and rmse = 1.33 kcal/mol, see Tables 2 and S2).
Table 3 lists mGPfusion’s rmse for different number of simultaneous
mutations. The model accuracy in fact improves up to 6 mutations.
This is explained by the training set often containing the same single
point mutations that appear in variants with multiple mutations. The
model can then infer the combined effect of pointwise mutations. The
model seems to fail when predicting the effects of 7-9 simultaneous mu-
tations. Most of these mutations (8/12) are for Ribonuclease (1RGG)
and their effects seem to be exceptionally difficult to predict. This may
be because only few of the point mutations that are part of the multiple
mutations are present in the training data. However, these mutations
seem to be exceptionally difficult to predict for Rosetta as well, which
could indicate that the experimental measurements concerning these
mutations are not quite accurate. PoPMuSiC and mCSM are unable
to predict multiple mutations, while Rosetta supports them, but its
rmse accuracy decreases already with two mutations.
mutations 1 2 3 4 5 6 7 8 9 10
occurences 1211 207 52 42 4 8 3 3 6 1
mGPfusion 1.07 1.06 0.80 0.51 0.40 1.01 3.02 5.89 5.16 0.25
mGPfusion, only B62 1.11 1.12 0.77 0.59 0.29 1.14 3.00 6.78 5.56 0.11
mGP 1.04 1.03 0.61 0.50 0.18 0.92 3.23 6.18 6.75 0.08
mGP, only B62 1.26 0.96 0.65 0.83 0.26 1.14 2.95 6.90 6.57 0.05
Rosetta scaled 1.35 2.10 1.92 2.94 2.29 2.32 2.93 6.75 7.28 2.69
Rosetta 1.63 2.27 2.11 3.78 2.93 2.21 2.92 5.80 7.45 3.42
Table 3: Root-mean-square errors for different number of simultaneous
mutations for all 15 proteins, with models trained by leave-one-out cross-
validation. Rosetta is added for comparison.
With multiple mutations, the decrease in performance between the
position and mutation level cross-validations becomes clearer than with
single mutations. With the position level cross-validation the stability
effects of multiple mutations are predicted multiple times, which partly
explains this loss of accuracy. For example, the effects of mutants with
nine different simultaneous mutations, which were the most difficult
cases in the mutation level cross-validation, are predicted nine times.
Surprisingly, mGPfusion trained with protein level cross-validation
achieves higher correlation and smaller errors than Rosetta; mGPfusion
utilising simulated ∆∆G values for only single mutations, can predict
the stability effects of multiple mutations better than Rosetta.
3.3 Uncertainty of the predictions
Gaussian processes provide a mean µ(x) and a standard deviation σ(x)
for the stability prediction of a protein variant x. The standard de-
viation allows estimation of the prediction accuracy even without test
data. Figure 1 h) visualises the uncertainty of a few predictions made
for the protein G (1PGA) when mutation level cross-validation is used.
The estimated standard deviation allows a user to automatically iden-
tify low quality predictions that can appear e.g. in parts of the input
protein space from which less data is included in model training. Con-
versely, in order to minimise the amount of uncertainty in the mGPfu-
sion predictions, estimated standard deviation can be used to guide next
experiments. The probabilistic nature of the predictions also admits an
alternative error measure of negative log probability density (NLPD)
nlpd = −∑Ni=1 log p(yi|µ(xi), σ2(xi)), which can naturally take into
account the prediction variance.
3.4 Effect of training set size
The results presented in Sections 3.1–3.3 used all available data for
training with cross-validation to obtain unbiased performance mea-
sures. The inclusion of thousands of simulated variants allows the model
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to learn accurate models with less experimentally measured variants.
Hence, we study how the mGPfusion model with or without simulated
data performs with reduced number of experimental observations. To
facilitate this, we randomly selected subsets of experimental data of
size 0, 10, 20, and so on. We learned the mGP and mGPfusion models
with these reduced experimental data sets while always using the full
simulated data sets. This also allows us to estimate how the models
work with different number of cross-validation folds. For example, the
point of a learning curve which utilises 2/3 or 4/5 of the training data
correspond to an average of multiple 3-fold or 5-fold cross-validations,
respectively.
The learning curve in Figure 4a) shows how the averaged correlation
for protein 2LZM improves when the size of the experimental data set
increases. The right-most values at N = 348 are obtained with leave-
one-out cross-validation. The inclusion of simulated data in mGPfusion
(dark blue line) consistently improves the performance of mGP, which
is trained without simulated data. Figure 4b) illustrate the difference
in root mean square error. Learning curves for all proteins listed in
Table 1 can be found from the Supplementary Figures S6-S8. When
the number of experimental samples is zero, the mGPfusion model is
trained solely using the simulated data with scaling 0.57yS , and the
mGP model predicts the stability effect of every mutation as zero. The
last point on the learning curves is obtained with mutation level cross-
validation (see Tables 2 and S2).
Figure 4: a) Correlation and b) root mean square error of predictions made
by models with different number of experimental training samples for T4
Lysozyme (2LZM). The results of Rosetta, mCSM and PoPMuSiC are in-
variant to training data (because mCSM and PoPMuSiC are pre-trained),
and are thus constant lines. For both figures, an average of 100 randomly
selected training sets is taken at each point.
3.5 Effect of data fusion and multiple substitution
matrices
In the beginning of the learning curves, when only little training data is
available, mGPfusion quite consistently outperforms the mGP model,
demonstrating that the additional simulated data improves the predic-
tion accuracy. However, when more training data becomes available,
the performance of mGP model is almost as good or sometimes even
better than the performance of the mGPfusion model. This shows that
if enough training data is available, it is not necessary to simulate addi-
tional data in order to obtain accurate predictions. Table 2 also shows,
that the data fusion can compensate the lack of relevant training data
– with the mGPfusion models that utilise the additional data, the de-
crease in accuracy is smaller when position level cross-validation is used
instead of mutation level cross-validation, than with the mGP models.
The varying weights for the base kernels between different pro-
teins (shown in Figure 2) already illustrated that different proteins
benefit from different similarity measures for amino acid substitutions.
The learning curves also support this observation – with some of the
proteins mGPfusion model trained with only one kernel that utilises
BLOSUM62, provides approximately as good results as the mGPfu-
sion model trained with multiple kernels. However, with many of the
proteins, utilising just BLOSUM62 does not seem to be sufficient and
the accuracy of the model can be improved by using different substi-
tution matrices. Prior knowledge of appropriate substitution models
for each protein could enable creation of accurate prediction models
with just one substitution model, but the MKL seems to be a good
tool for selecting suitable substitution models when such knowledge is
not available. It seems that the data fusion and number or relevance
of used substitution matrices can compensate each other – the learning
curves show, that the difference between mGPfusion models trained
with one or multiple kernels is smaller than the difference between the
mGP models utilising one or multiple kernels. This indicates that if ad-
ditional simulated data is exploited, the use of multiple or appropriate
substitution models is not as important than without the data fusion.
On the other hand, if data fusion is not applied, the use of MKL can
more significantly improve the accuracy of the mGP model.
3.6 Effect of the Bayesian transformation on
Rosetta
The Bayesian scaling of simulated Rosetta values, proposed in Sec-
tion 2.2, improves the match of Rosetta simulated values to empirical
∆∆G values even without using the Gaussian process framework. The
Bayesian scaling improves the performance of standard Rosetta sim-
ulations from ρ = 0.55 and rmse = 1.63 kcal/mol to ρ = 0.65 and
rmse = 1.35 kcal/mol (see Table 2 and Supplementary Table S2). This
shows that the scaling proposed by Kellogg et al. (2011) indeed is not
always the optimal scaling and significant improvements can be gained
by optimising the scaling using a set of training data.
Figure 1 g) visualises the Bayesian scaling for protein 1PGA, where
the very destabilising ∆∆G values are dampened by the scaling (black
dots) to less extreme values by matching the scaled simulated values to
the experimental points (blue circles). The black dots along the scaling
curve indicate the grid of point mutations after transformation. The
scaling variance σ2T is indicated by the green region’s vertical width,
and on the right panel. The scaling tends to dampen very small values
into less extreme stabilities, while it also estimates higher uncertainties
for stability values further away from ∆∆G = 0. However, the scalings
vary between different proteins, as can be seen from the transformations
for each of the 15 proteins presented in Supplementary Figure S9.
4 Conclusions
We present a novel method mGPfusion for predicting stability effects of
both single and multiple simultaneous mutations. mGPfusion utilises
structural information in form of contact maps and integrates that with
amino acid residues and combines both experimental and comprehen-
sive simulated measurements of mutations’ stability effects. In con-
trast to earlier general-purpose stability models, mGPfusion model is
protein-specific by design, which improves the accuracy but necessitates
having a set of experimental measurements from the protein. In prac-
tise small datasets of 10–20 experimental observations were found to
provide state-of-the-art accuracy models when supplemented by large
simulation datasets.
An important advantage over most state-of-the-art machine learn-
ing methods is that mGPfusion is able to predict the effects of multiple
simultaneous mutations in addition to single point mutations. Our
experiments show that mGPfusion is reliable in predicting up to six
simultaneous mutations in our dataset. Furthermore, the Gaussian
process framework provide a way to estimate the (un)certainty of the
predictions even without a separate test set. We additionally proposed
a novel Bayesian scaling method to re-calibrate simulated protein sta-
bility values against experimental observations. This is a crucial part of
the mGPfusion model, and also alone improved protein-specific Rosetta
stability predictions by calibrating them using experimental data.
mGPfusion is best suited for a situation, where a protein is thor-
oughly experimented on and accurate predictions for stability effects
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upon mutations are needed. It takes some time to set up the frame-
work and train the model, but after that new predictions can be made
in fractions of a second. The most time-consuming part is running the
simulations with Rosetta, at least when the most accurate protocol 16
is used. Simulating all 19 possible point mutations for one position
took about 12 hours, but simulations for different positions can be run
on parallel. The time needed for training the prediction model depends
on the amount of experimental and simulated training data. With no
simulated data, the training time ranged from few seconds to few min-
utes. With data fusion and a single kernel, the training time was under
an hour. With data fusion and MKL with 21 kernels, the training time
was from a few minutes to a day.
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Figure S5: The stability of a protein is determined by the thermodynamic and kinetic stabilities, ∆Gt and ∆Gk, respectively. We only consider the
thermodynamic stability.
Figure S6: Priors presented by Equation 2. Here µd = −1.5, the most likely value for −a. Other hyperparameter values are presented in Table S4.
Table S4: Values for the hyperparameters used in the priors of a, b, c, d, σE and σS presented in Equations 2 and 6, respectively.
a b c d σE σS
αa = 2 αb = 1.3 αc = 2 µd = −a αE = 2.5 αS = 50
βa = 1.5 βb = 2 βc = 5 σd = 0.15 βE = 0.02 βS = 0.007
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The partial derivatives of the marginal likelihood with respect to the parameters φ are obtained from Equation (9) as follows:
∂
∂φj
log p(y|X,φ) =1
2
yTK−1φ
∂Kφ
∂φj
K−1φ y −
1
2
tr
(
K−1φ
∂Kφ
∂φj
)
=
1
2
tr
((
ααT −K−1φ
) ∂Kφ
∂θj
)
,
(S11)
where α = K−1φ y, Kφ is determined as
Kφ =
M∑
m=1
wmK
γm
m + diag
 σ0σE1NE
σE1NE + σS1NS + tσT
2
and the partial derivatives of Kφ with respect to the optimised parameters are
∂Kφ
∂σE
=diag
 02σE1NE
2 (σE1NE + σS1NS + tσT )
 (S12)
∂Kφ
∂σR
=diag
 00NE
2 (σE1NE + σS1NS + tσT )
 (S13)
∂Kφ
∂t
=diag
 00NE
2 (σE1NE + σS1NS + t)σT
 (S14)
∂Kφ
∂wm
=Kγmm (S15)
∂Kφ
∂γm
=wmK
γm
m logKm (S16)
Correlation ρ and root-mean-square error rmse for the predictions are determined as
ρ =
∑N∗
i=1(yi − y¯)(µ(xi)− µ¯)√∑N∗
i=1(yi − y¯)2
∑N∗
i=1(µ(xi)− µ¯)2
(S17)
rmse =
√√√√ 1
N∗
N∗∑
i=1
(yi − µ(xi))2, (S18)
where y¯ is the mean of the experimentally measured values, µ(xi) is prediction mean, µ¯ is the average of all prediction means, and N∗ is the
number of predictions.
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Figure S7: Mutation-level predictions for all 15 proteins presented in Table 1. The predictions are coloured by the number of simultaneous mutations.
11
Figure S8: Position-level predictions for all 15 proteins. When the effects of a mutant are predicted multiple times, they are connected by a line.
12
Table S5: (Continues on the next page)Comparison of different methods on the 15 protein dataset with respect to ρ and rmse. Off-the-shelf implementations
of Rosetta, mCSM and PoPMuSiC are used directly without cross-validation.
Correlation ρ rmse
Point mutations Multiple mutations All mutations Point mutations Multiple mutations All mutations
cross-validation level cross-validation level cross-validation level cross-validation level cross-validation level cross-validation level
Protein Method mut. pos. prot. mut. pos. prot. mut. pos. prot. mut. pos. prot. mut. pos. prot. mut. pos. prot.
2LZM
mGPfusion 0.87 0.80 0.75 0.96 0.83 0.64 0.90 0.76 0.68 0.82 1.02 1.12 0.57 1.53 2.14 0.76 1.30 1.43
mGPfusion, only B62 0.86 0.77 0.75 0.96 0.87 0.64 0.90 0.82 0.69 0.84 1.08 1.12 0.59 1.16 2.11 0.79 1.13 1.42
mGP 0.86 0.59 - 0.97 0.85 - 0.90 0.72 - 0.82 1.34 - 0.48 1.24 - 0.75 1.29 -
mGP, only B62 0.75 0.37 - 0.94 0.77 - 0.82 0.61 - 1.12 1.93 - 0.78 1.44 - 1.05 1.70 -
Rosetta scaled 0.74 0.73 - 0.68 0.66 - 0.70 0.65 - 1.05 1.06 - 1.65 1.84 - 1.23 1.51 -
Rosetta 0.75 0.68 0.71 1.13 1.93 1.37
mCSM 0.57 - - 1.27 - -
PoPMuSiC 0.71 - - 1.11 - -
1BNI
mGPfusion 0.77 0.64 0.62 0.86 0.70 0.39 0.77 0.55 0.57 1.21 1.37 1.69 1.28 2.49 2.17 1.22 1.67 1.75
mGPfusion, only B62 0.74 0.61 0.62 0.84 0.79 0.40 0.74 0.60 0.57 1.27 1.45 1.69 1.24 2.03 2.14 1.27 1.60 1.75
mGP 0.81 0.65 - 0.86 0.82 - 0.80 0.63 - 1.08 1.40 - 1.32 2.00 - 1.11 1.55 -
mGP, only B62 0.61 0.48 - 0.87 0.85 - 0.63 0.41 - 1.61 2.32 - 1.15 1.67 - 1.57 2.20 -
Rosetta scaled 0.59 0.58 - 0.17 0.29 - 0.53 0.45 - 1.58 1.58 - 2.51 2.90 - 1.70 1.94 -
Rosetta 0.62 0.18 0.56 1.70 2.33 1.77
mCSM 0.60 - - 1.62 - -
PoPMuSiC 0.66 - - 1.53 - -
1VQB
mGPfusion 0.67 0.50 0.49 0.93 0.83 0.75 0.76 0.69 0.60 1.71 1.94 2.25 1.15 1.62 2.06 1.59 1.82 2.20
mGPfusion, only B62 0.65 0.53 0.50 0.91 0.82 0.73 0.75 0.69 0.58 1.75 1.94 2.25 1.35 1.82 2.43 1.66 1.89 2.30
mGP 0.79 0.12 - 0.96 0.70 - 0.85 0.50 - 1.41 2.41 - 0.70 1.97 - 1.27 2.24 -
mGP, only B62 0.79 0.29 - 0.97 0.75 - 0.85 0.55 - 1.50 2.89 - 0.63 2.30 - 1.33 2.66 -
Rosetta scaled 0.47 0.46 - 0.71 0.68 - 0.57 0.59 - 1.99 2.00 - 1.90 1.96 - 1.97 1.99 -
Rosetta 0.49 0.73 0.59 2.26 2.06 2.21
mCSM 0.53 - - 2.24 - -
PoPMuSiC 0.51 - - 2.29 - -
1LZ1
mGPfusion 0.75 0.59 0.58 1.00 0.11 -1.00 0.77 0.57 0.52 0.83 0.99 1.06 0.56 2.40 3.75 0.83 1.07 1.16
mGPfusion, only B62 0.73 0.56 0.59 1.00 0.05 -1.00 0.76 0.56 0.53 0.86 1.03 1.06 1.10 2.41 3.51 0.87 1.10 1.14
mGP 0.75 0.39 - 1.00 0.56 - 0.78 0.47 - 0.81 1.15 - 0.13 1.65 - 0.80 1.17 -
mGP, only B62 0.71 -0.31 - 1.00 0.42 - 0.74 0.21 - 0.91 1.43 - 0.27 2.36 - 0.90 1.47 -
Rosetta scaled 0.57 0.55 - -1.00 -1.00 - 0.53 0.46 - 0.99 1.01 - 3.23 3.25 - 1.07 1.15 -
Rosetta 0.59 -1.00 0.55 1.04 3.41 1.12
mCSM 0.67 - - 0.97 - -
PoPMuSiC 0.64 - - 0.95 - -
2CI2
mGPfusion 0.73 0.72 0.64 0.95 0.87 0.85 0.82 0.81 0.71 0.85 0.90 1.07 0.55 0.80 1.21 0.80 0.86 1.10
mGPfusion, only B62 0.69 0.67 0.63 0.92 0.86 0.86 0.79 0.79 0.72 0.91 0.97 1.07 0.71 1.01 1.12 0.87 0.99 1.08
mGP 0.65 0.61 - 0.92 0.79 - 0.76 0.72 - 0.95 1.02 - 0.66 1.01 - 0.90 1.02 -
mGP, only B62 0.51 0.74 - 0.92 0.71 - 0.68 0.63 - 1.16 1.39 - 0.71 1.40 - 1.08 1.39 -
Rosetta scaled 0.60 0.60 - 0.61 0.61 - 0.63 0.63 - 1.00 1.00 - 1.27 1.27 - 1.06 1.11 -
Rosetta 0.63 0.62 0.65 1.09 1.30 1.13
mCSM 0.74 - - 0.86 - -
PoPMuSiC 0.75 - - 0.85 - -
1PGA
mGPfusion 0.68 0.47 0.69 0.90 0.35 0.32 0.85 0.43 0.50 1.26 1.54 1.64 0.53 2.09 2.74 0.88 2.00 2.38
mGPfusion, only B62 0.82 0.59 0.71 0.76 0.60 0.62 0.81 0.53 0.70 0.87 1.22 1.06 0.69 0.95 0.88 0.83 1.13 1.02
mGP 0.62 0.61 - 0.93 -0.24 - 0.84 -0.14 - 1.40 1.58 - 0.45 3.01 - 0.94 2.81 -
mGP, only B62 0.57 -0.46 - 0.92 -0.08 - 0.81 0.06 - 1.53 1.73 - 0.47 2.07 - 1.02 2.01 -
Rosetta scaled 0.69 0.59 - 0.09 0.07 - 0.24 0.11 - 1.21 1.42 - 2.81 3.09 - 2.33 2.87 -
Rosetta 0.69 0.03 0.28 1.70 3.51 2.95
mCSM -0.10 - - 1.94 - -
PoPMuSiC 0.28 - - 1.89 - -
2RN2
mGPfusion 0.79 0.58 0.71 0.78 0.60 0.61 0.79 0.53 0.70 0.91 1.21 1.05 0.67 1.01 0.91 0.86 1.14 1.02
mGPfusion, only B62 0.82 0.59 0.71 0.76 0.60 0.62 0.81 0.53 0.70 0.87 1.22 1.59 0.69 0.95 1.18 0.83 1.13 1.51
mGP 0.77 0.12 - 0.75 0.42 - 0.77 0.22 - 0.93 1.45 - 0.74 1.21 - 0.89 1.36 -
mGP, only B62 0.83 0.09 - 0.77 0.42 - 0.82 0.23 - 0.82 1.45 - 0.68 1.20 - 0.80 1.36 -
Rosetta scaled 0.66 0.64 - 0.48 0.50 - 0.62 0.57 - 1.09 1.13 - 1.20 1.08 - 1.12 1.11 -
Rosetta 0.70 0.47 0.65 1.07 1.25 1.11
mCSM 0.71 - - 1.04 - -
PoPMuSiC 0.71 - - 1.16 - -
1CSP
mGPfusion 0.85 0.23 0.33 0.92 0.73 0.48 0.92 0.75 0.38 0.64 1.04 1.10 0.91 1.66 2.58 0.75 1.45 1.80
mGPfusion, only B62 0.86 0.22 0.34 0.91 0.69 0.59 0.91 0.72 0.54 0.65 1.04 1.10 0.96 1.87 2.13 0.78 1.60 1.57
mGP 0.88 -0.06 - 0.94 0.75 - 0.94 0.77 - 0.54 1.07 - 0.76 1.51 - 0.63 1.36 -
mGP, only B62 0.87 -0.37 - 0.92 0.71 - 0.92 0.72 - 0.60 1.12 - 0.86 1.59 - 0.71 1.43 -
Rosetta scaled 0.23 0.20 - 0.68 0.69 - 0.59 0.64 - 1.04 1.06 - 2.19 2.29 - 1.58 1.92 -
Rosetta 0.33 0.68 0.60 1.11 1.92 1.47
mCSM 0.42 - - 1.02 - -
PoPMuSiC 0.48 - - 0.99 - -
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Table S5: (Continued) Comparison of different methods on the 15 protein dataset with respect to ρ and rmse. Off-the-shelf implementations of Rosetta,
mCSM and PoPMuSiC are used directly without cross-validation.
Correlation ρ rmse
Point mutations Multiple mutations All mutations Point mutations Multiple mutations All mutations
cross-validation level cross-validation level cross-validation level cross-validation level cross-validation level cross-validation level
Protein Method mut. pos. prot. mut. pos. prot. mut. pos. prot. mut. pos. prot. mut. pos. prot. mut. pos. prot.
1BVC
mGPfusion 0.41 0.43 0.48 -0.28 -0.25 -0.63 0.08 -0.09 0.09 0.74 0.72 1.65 1.64 1.48 2.70 1.09 1.21 2.02
mGPfusion, only B62 0.50 0.48 0.48 -0.25 -0.25 -0.66 0.14 -0.07 0.14 0.70 0.71 1.65 1.62 1.47 2.43 1.06 1.20 1.92
mGP -0.05 -0.12 - -0.10 -0.21 - -0.13 -0.23 - 0.99 1.00 - 1.30 1.35 - 1.09 1.21 -
mGP, only B62 -0.05 0.06 - -0.11 -0.21 - -0.14 -0.20 - 0.99 0.99 - 1.29 1.33 - 1.09 1.20 -
Rosetta scaled 0.42 0.40 - -0.63 -0.57 - 0.09 -0.09 - 0.75 0.76 - 1.65 1.45 - 1.10 1.20 -
Rosetta 0.47 -0.65 0.14 1.67 2.45 1.94
mCSM 0.47 - - 1.00 - -
PoPMuSiC 0.60 - - 0.85 - -
4LYZ
mGPfusion 0.61 0.27 0.34 0.95 0.57 0.66 0.65 0.34 0.35 1.47 1.65 3.46 0.69 1.02 2.35 1.35 1.45 3.26
mGPfusion, only B62 0.59 0.30 0.34 0.96 0.64 0.64 0.64 0.40 0.35 1.48 1.64 3.50 0.57 0.93 2.17 1.35 1.43 3.27
mGP 0.65 -0.05 - 0.96 0.46 - 0.68 0.18 - 1.38 1.78 - 0.36 1.15 - 1.24 1.59 -
mGP, only B62 0.62 0.27 - 0.97 0.47 - 0.64 0.21 - 1.48 1.84 - 0.31 1.16 - 1.33 1.63 -
Rosetta scaled 0.29 0.28 - 0.70 0.68 - 0.33 0.34 - 2.26 2.22 - 1.22 1.29 - 2.09 1.94 -
Rosetta 0.33 0.71 0.35 3.61 2.05 3.35
mCSM 0.55 - - 1.43 - -
PoPMuSiC 0.59 - - 1.45 - -
1RTB
mGPfusion 0.92 0.81 0.70 0.78 0.74 0.75 0.86 0.71 0.68 1.25 1.73 2.44 2.22 2.24 1.71 1.40 1.85 2.36
mGPfusion, only B62 0.89 0.79 0.70 0.73 0.73 0.67 0.86 0.75 0.69 1.48 1.85 2.44 1.82 1.81 1.90 1.53 1.84 2.38
mGP 0.92 0.69 - 0.78 0.30 - 0.76 0.18 - 1.26 2.62 - 3.44 3.39 - 1.69 2.81 -
mGP, only B62 0.91 0.58 - 0.48 0.58 - 0.85 0.16 - 1.67 3.37 - 2.12 2.11 - 1.73 3.14 -
Rosetta scaled 0.65 0.61 - 0.73 0.73 - 0.67 0.65 - 1.99 2.08 - 1.63 1.62 - 1.95 1.99 -
Rosetta 0.69 0.73 0.70 2.45 2.01 2.40
mCSM 0.68 - - 2.33 - -
PoPMuSiC 0.72 - - 2.22 - -
1PIN∗
mGPfusion 0.64 0.49 0.53 - - - 0.64 0.49 0.53 0.47 0.53 1.00 - - - 0.47 0.53 1.00
mGPfusion, only B62 0.59 0.51 0.53 - - - 0.59 0.51 0.53 0.50 0.54 1.00 - - - 0.50 0.54 1.00
mGP 0.61 0.40 - - - - 0.61 0.40 - 0.49 0.58 - - - - 0.49 0.58 -
mGP, only B62 0.23 0.25 - - - - 0.23 0.25 - 0.70 0.76 - - - - 0.70 0.76 -
Rosetta scaled 0.50 0.49 - - - - 0.50 0.49 - 0.54 0.54 - - - - 0.54 0.54 -
Rosetta 0.53 - 0.53 0.99 0.99
mCSM 0.72 - 0.72 0.59 - 0.59
PoPMuSiC 0.60 - 0.60 0.70 - 0.70
1RN1
mGPfusion 0.83 0.62 0.67 0.97 0.38 -0.19 0.84 0.55 0.65 0.85 1.17 1.18 0.19 0.91 1.28 0.81 1.13 1.19
mGPfusion, only B62 0.81 0.58 0.67 0.96 0.42 -0.01 0.81 0.51 0.66 0.92 1.24 1.18 0.35 0.77 0.99 0.88 1.17 1.17
mGP 0.74 0.04 - 0.99 0.62 - 0.75 0.04 - 1.06 1.75 - 0.12 0.58 - 1.01 1.61 -
mGP, only B62 0.77 0.27 - 0.99 0.50 - 0.78 0.10 - 1.00 1.78 - 0.13 0.82 - 0.95 1.66 -
Rosetta scaled 0.63 0.57 - 0.21 0.18 - 0.61 0.54 - 1.12 1.18 - 0.98 1.01 - 1.10 1.15 -
Rosetta 0.67 0.20 0.65 1.20 1.24 1.20
mCSM 0.76 - - 0.97 - -
PoPMuSiC 0.62 - - 1.14 - -
1RGG
mGPfusion 0.69 0.51 0.61 0.42 0.66 0.96 0.52 0.52 0.73 1.41 1.70 1.56 5.67 5.95 4.20 2.65 4.75 2.23
mGPfusion, only B62 0.69 0.52 0.61 0.22 0.30 0.93 0.40 0.33 0.55 1.42 1.68 1.56 6.21 6.14 5.43 2.85 4.90 2.64
mGP 0.71 -0.61 - 0.19 0.08 - 0.35 -0.05 - 1.38 2.24 - 6.81 6.88 - 3.05 5.53 -
mGP, only B62 0.72 -0.53 - 0.08 0.07 - 0.30 -0.00 - 1.53 2.01 - 6.89 6.77 - 3.14 5.41 -
Rosetta scaled 0.58 0.43 - 0.78 0.86 - 0.42 0.51 - 1.57 1.76 - 7.08 7.24 - 3.23 5.74 -
Rosetta 0.60 0.77 0.39 1.58 6.90 3.16
mCSM 0.77 - - 1.36 - -
PoPMuSiC 0.65 - - 1.54 - -
1BPI
mGPfusion 0.68 0.67 0.51 -0.39 -0.02 -0.06 0.85 -0.13 0.12 1.27 1.28 1.83 2.17 7.66 7.69 1.40 3.64 3.11
mGPfusion, only B62 0.64 0.65 0.51 -0.53 0.33 0.21 0.81 0.05 0.12 1.32 1.32 1.82 2.86 7.07 7.70 1.57 3.40 3.11
mGP 0.56 0.57 - -0.29 0.52 - 0.83 0.84 - 1.43 1.43 - 1.72 4.19 - 1.47 2.28 -
mGP, only B62 0.43 0.58 - -0.55 0.46 - 0.76 0.70 - 1.68 1.73 - 2.52 6.58 - 1.80 3.34 -
Rosetta scaled 0.52 0.52 - 0.23 -0.00 - 0.08 -0.08 - 1.52 1.52 - 7.43 7.43 - 2.88 3.62 -
Rosetta 0.51 -0.00 0.13 1.80 7.68 3.09
mCSM 0.71 - - 1.26 - -
PoPMuSiC 0.72 - - 1.31 - -
total
mGPfusion 0.81 0.70 0.56 0.88 0.61 0.49 0.83 0.64 0.52 1.07 1.26 1.61 1.33 2.45 2.53 1.13 1.87 1.84
mGPfusion, only B62 0.79 0.69 0.56 0.86 0.64 0.50 0.82 0.66 0.52 1.11 1.30 1.62 1.43 2.40 2.50 1.18 1.85 1.84
mGP 0.81 0.51 - 0.86 0.52 - 0.83 0.50 - 1.04 1.54 - 1.44 2.65 - 1.14 2.09 -
mGP, only B62 0.76 0.34 - 0.86 0.55 - 0.80 0.49 - 1.26 1.95 - 1.45 2.56 - 1.30 2.23 -
Rosetta scaled 0.65 0.63 - 0.51 0.39 - 0.60 0.48 - 1.35 1.38 - 2.49 2.99 - 1.66 2.22 -
Rosetta 0.55 0.40 0.49 1.63 2.74 1.92
mCSM 0.61 - - 1.40 - -
PoPMuSiC 0.64 - - 1.37 - -
∗ dataset for 1PIN contained no multiple mutations.
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Table S6: Comparison of different methods on the 15 protein dataset with respect to ρ and rmse after removing 10% of predictions with largest errors.
Mutation, position, and protein are referred to as mut., pos., and prot., respectively. Off-the-shelf implementations of Rosetta, mCSM and PoPMuSiC are
used directly without cross-validation.
Results after 10 %
outlier removal
Correlation ρ rmse
Point mutations Multiple mutations All mutations Point mutations Multiple mutations All mutations
cross-validation level cross-validation level cross-validation level cross-validation level cross-validation level cross-validation level
Method mut. pos. prot. mut. pos. prot. mut. pos. prot. mut. pos. prot. mut. pos. prot. mut. pos. prot.
mGPfusion 0.87 0.77 0.75 0.97 0.84 0.63 0.92 0.81 0.71 0.69 0.85 0.93 0.62 1.55 1.90 0.67 1.15 1.13
mGPfusion, only B62 0.86 0.73 0.75 0.96 0.84 0.65 0.91 0.80 0.72 0.69 0.85 0.93 0.64 1.43 1.85 0.67 1.10 1.12
mGP 0.89 0.57 - 0.98 0.76 - 0.93 0.74 - 0.65 1.01 - 0.49 1.66 - 0.62 1.23 -
mGP, only B62 0.86 0.27 - 0.97 0.76 - 0.91 0.66 - 0.73 1.30 - 0.54 1.48 - 0.69 1.37 -
Rosetta scaled 0.80 0.78 - 0.73 0.71 - 0.78 0.75 - 0.84 0.87 - 1.67 1.99 - 1.00 1.31 -
Off-the-shelf implementations with no cross-validation
Rosetta 0.75 0.67 0.73 0.94 1.85 1.11
mCSM 0.71 - - 0.89 - -
PoPMuSiC 0.73 - - 0.86 - -
Figure S9: rmse with different amount of predictions, when predictions are sorted by the error. Position level cross-validation was used for mGPfusion,
mGP and Rosetta scaled.
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Figure S10: Learning curves.
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Figure S11: Learning curves.
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Figure S12: Learning curves.
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Figure S13: Transformations for all 15 proteins presented in Table 1. The red circles mark the simulated ∆∆G-values yS with respect to the experimental
measured ∆∆G-values yE . Thin black lines show possible transformations for yS , whereas the thick black line shows the selected transformation from yS
to y˜S .
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